Pericardial Fluid Metastatic Tumor Distribution and Fluid Volume Analysis: A 10-Year Institutional Experience
Acta Cytologica · 19.06.2026 · 1-10
DOI: 10.1159/000553127 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Cytologica, online erschienen am 19.06.2026. Verfasst von Mason Marshall und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
Introduction
Cytologic examination of pericardial effusions is critical for detecting malignant involvement, which carries a dismal prognosis. However, contemporary large-scale studies characterizing the distribution of metastatic tumors and the impact of submitted fluid volume on diagnostic yield remain limited. This study evaluates the distribution of metastatic tumors in malignant pericardial effusions and examines the relationship between specimen volume and likelihood of malignant cytologic diagnosis in a large institutional cohort.
Methods
A 10-year retrospective review was performed of all pericardial fluid cytology specimens accessioned at a large tertiary academic medical center. Clinical, radiologic, and cytologic findings were recorded. Cases categorized as suspicious for malignant cells (SFM) or malignant (MAL) were included in the metastatic tumor distribution analyses after reviewing tumor cytomorphology and immunohistochemical profiles in conjunction with clinical and radiologic data. Specimen volumes were stratified by diagnostic category, and threshold-based analyses at 50 mL and 100 mL were compared across diagnostic categories using statistical methods.
Results
A total of 1,591 cases were identified from patients with a median age 65 years and a male-to-female ratio of 0.98. Most cases were negative for malignant cells (NFM) (78.6%), while 14.4% classified as malignant (MAL). Among malignant cases (SFM + MAL), carcinomas accounted for 83.5%, followed by hematolymphoid malignancies (14.0%); mesotheliomas, sarcomas, and melanomas were rare. Lung carcinoma was the most common primary tumor (48.0%), followed by breast carcinoma (16.0%) and B-cell lymphoma (7.8%). Submitted specimen volume increased progressively across diagnostic categories (p = 0.0010), with malignant cases demonstrating higher median volumes than negative cases. Specimens ≥50 mL showed a significantly higher malignancy rate compared with those
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
- University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
- Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA, khaders@upmc.edu.
Zitieren
APA
Marshall, M., Ramseyer, T., Cuda, J., Jurado, A., Pantanowitz, J., Pantanowitz, L., & Khader, S. (2026). Pericardial Fluid Metastatic Tumor Distribution and Fluid Volume Analysis: A 10-Year Institutional Experience. Acta Cytologica, 1-10. https://doi.org/10.1159/000553127
Vancouver
Marshall M, Ramseyer T, Cuda J, Jurado A, Pantanowitz J, Pantanowitz L, et al. Pericardial Fluid Metastatic Tumor Distribution and Fluid Volume Analysis: A 10-Year Institutional Experience. Acta Cytologica. 2026:1-10. doi:10.1159/000553127
BibTeX
@article{Marshall2026,
author = {Marshall, Mason and Ramseyer, Timothy and Cuda, Jacqueline and Jurado, Andrea and Pantanowitz, Joshua and Pantanowitz, Liron and Khader, Samer},
title = {Pericardial Fluid Metastatic Tumor Distribution and Fluid Volume Analysis: A 10-Year Institutional Experience},
journal = {Acta Cytologica},
year = {2026},
pages = {1--10},
doi = {10.1159/000553127}
}
EUVIMED